GlassScriptPhysician profile
Alex Michael Ng
NPI 1083933675
$2,708.73
in general payments reported to CMS, 2019-2025
15 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $1,000 · 2022: $28.51 · 2023: $321 · 2024: $503 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.76 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $1,000.00 | 2020 | |
| United Therapeutics Corporation | $473.03 | 2023-2025 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $373.06 | 2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.62 | 2019-2025 | Ofev, Jascayd |
| Baxter Healthcare | $154.10 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Pulmonx Corporation | $147.92 | 2019 | |
| Celgene Corporation | $89.20 | 2023 | |
| Zambon USA LTD. | $71.03 | 2024 | |
| Ani Pharmaceuticals, INC. | $35.98 | 2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $26.78 | 2025 | Tobi Podhaler |
| Inspire Medical Systems, INC. | $24.80 | 2024 | Inspire |
| Astellas Pharma US INC | $21.97 | 2023 | Cresemba |
| Astrazeneca Pharmaceuticals LP | $17.81 | 2024 | Fasenra |
| Ambu INC. | $16.10 | 2023 | |
| Electromed, INC. | $14.33 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.